NHI National Health Investors Inc

Price (delayed)

$62.83

Market cap

$2.73B

P/E Ratio

20.07

Dividend/share

$3.6

EPS

$3.13

Enterprise value

$3.84B

Incorporated in 1991, National Health Investors, Inc. is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. ...

Highlights
National Health Investors's EPS has surged by 111% YoY and by 28% QoQ
The net income has soared by 104% year-on-year and by 29% since the previous quarter
The gross margin has declined by 2.6% year-on-year

Key stats

What are the main financial stats of NHI
Market
Shares outstanding
43.41M
Market cap
$2.73B
Enterprise value
$3.84B
Valuations
Price to book (P/B)
2.18
Price to sales (P/S)
8.52
EV/EBIT
19.81
EV/EBITDA
14.56
EV/Sales
12.01
Earnings
Revenue
$319.84M
EBIT
$193.81M
EBITDA
$263.79M
Free cash flow
$191.93M
Per share
EPS
$3.13
Free cash flow per share
$4.42
Book value per share
$28.89
Revenue per share
$7.37
TBVPS
$57.35
Balance sheet
Total assets
$2.49B
Total liabilities
$1.21B
Debt
$1.14B
Equity
$1.25B
Working capital
N/A
Liquidity
Debt to equity
0.91
Current ratio
N/A
Quick ratio
N/A
Net debt/EBITDA
4.22
Margins
EBITDA margin
82.5%
Gross margin
87.6%
Net margin
42.4%
Operating margin
55.4%
Efficiency
Return on assets
5.4%
Return on equity
10.7%
Return on invested capital
5.3%
Return on capital employed
N/A
Return on sales
60.6%
Dividend
Dividend yield
5.73%
DPS
$3.6
Payout ratio
115%

NHI stock price

How has the National Health Investors stock price performed over time
Intraday
1.63%
1 week
1.26%
1 month
7.44%
1 year
26.29%
YTD
12.5%
QTD
12.5%

Financial performance

How have National Health Investors's revenue and profit performed over time
Revenue
$319.84M
Gross profit
$280.25M
Operating income
$177.12M
Net income
$135.65M
Gross margin
87.6%
Net margin
42.4%
The operating income has soared by 118% year-on-year and by 63% since the previous quarter
The net income has soared by 104% year-on-year and by 29% since the previous quarter
The operating margin has soared by 90% YoY and by 59% from the previous quarter
The net margin has surged by 77% year-on-year and by 25% since the previous quarter

Growth

What is National Health Investors's growth rate over time

Valuation

What is National Health Investors stock price valuation
P/E
20.07
P/B
2.18
P/S
8.52
EV/EBIT
19.81
EV/EBITDA
14.56
EV/Sales
12.01
National Health Investors's EPS has surged by 111% YoY and by 28% QoQ
NHI's P/E is 12% less than its 5-year quarterly average of 22.7 and 4.9% less than its last 4 quarters average of 21.1
NHI's price to book (P/B) is 21% more than its last 4 quarters average of 1.8 and 15% more than its 5-year quarterly average of 1.9
The company's revenue rose by 15% YoY and by 2.8% QoQ
The stock's P/S is 14% more than its last 4 quarters average of 7.5 but 5% less than its 5-year quarterly average of 9.0

Efficiency

How efficient is National Health Investors business performance
The ROE has soared by 118% YoY and by 29% from the previous quarter
The return on assets has surged by 108% year-on-year and by 29% since the previous quarter
The ROIC has soared by 77% year-on-year and by 20% since the previous quarter
National Health Investors's return on sales has surged by 52% YoY and by 17% QoQ

Dividends

What is NHI's dividend history
DPS
$3.6
Dividend yield
5.73%
Payout ratio
115%
Recent dividends

Financial health

How did National Health Investors financials performed over time
The total assets is 105% more than the total liabilities
The debt is 9% smaller than the equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.